U.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $102.69 Million
Wall Street brokerages expect that U.S. Physical Therapy, Inc. (NYSE:USPH) will report $102.69 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for U.S. Physical Therapy’s earnings. The lowest sales estimate is $100.25 million and the highest is $105.13 million. U.S. Physical Therapy reported sales of $88.34 million during the same quarter last year, which indicates a positive year over year growth rate of 16.2%. The business is expected to announce its next earnings report on Thursday, November 2nd.
On average, analysts expect that U.S. Physical Therapy will report full year sales of $102.69 million for the current fiscal year, with estimates ranging from $404.13 million to $416.54 million. For the next financial year, analysts forecast that the business will report sales of $446.83 million per share, with estimates ranging from $437.53 million to $456.13 million. Zacks’ sales averages are an average based on a survey of research analysts that follow U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.60 by $0.01. The firm had revenue of $104.25 million for the quarter, compared to analysts’ expectations of $102.93 million. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%.
Several research analysts have recently weighed in on USPH shares. Zacks Investment Research raised shares of U.S. Physical Therapy from a “sell” rating to a “buy” rating and set a $72.00 target price on the stock in a research report on Saturday, May 13th. Jefferies Group LLC set a $65.00 target price on shares of U.S. Physical Therapy and gave the stock a “hold” rating in a research report on Friday, August 4th. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 target price on the stock in a research report on Monday, July 3rd. Finally, Cantor Fitzgerald started coverage on shares of U.S. Physical Therapy in a research report on Monday, July 24th. They issued an “overweight” rating and a $72.00 target price on the stock. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $68.50.
In related news, Director Bernard A. Harris, Jr. sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $62.00, for a total transaction of $310,000.00. Following the completion of the sale, the director now directly owns 26,422 shares in the company, valued at $1,638,164. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 4.30% of the company’s stock.
Hedge funds have recently bought and sold shares of the company. Trexquant Investment LP bought a new stake in U.S. Physical Therapy during the first quarter valued at approximately $666,000. Kings Point Capital Management boosted its stake in U.S. Physical Therapy by 2.4% in the first quarter. Kings Point Capital Management now owns 26,471 shares of the company’s stock valued at $1,729,000 after buying an additional 625 shares in the last quarter. Crawford Investment Counsel Inc. boosted its stake in U.S. Physical Therapy by 0.4% in the first quarter. Crawford Investment Counsel Inc. now owns 48,077 shares of the company’s stock valued at $3,139,000 after buying an additional 194 shares in the last quarter. Comerica Bank boosted its stake in U.S. Physical Therapy by 3.7% in the first quarter. Comerica Bank now owns 13,814 shares of the company’s stock valued at $909,000 after buying an additional 496 shares in the last quarter. Finally, Advisors Preferred LLC boosted its stake in U.S. Physical Therapy by 17.1% in the first quarter. Advisors Preferred LLC now owns 4,046 shares of the company’s stock valued at $264,000 after buying an additional 591 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was first published by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.dailypolitical.com/2017/08/12/u-s-physical-therapy-inc-usph-expected-to-post-quarterly-sales-of-102-69-million.html.
U.S. Physical Therapy (NYSE:USPH) opened at 61.70 on Friday. The company’s 50 day moving average is $62.62 and its 200 day moving average is $66.06. U.S. Physical Therapy has a 52 week low of $51.96 and a 52 week high of $78.00. The stock has a market cap of $776.25 million, a P/E ratio of 39.05 and a beta of 1.06.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 8th. Investors of record on Monday, August 21st will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 1.30%. The ex-dividend date of this dividend is Thursday, August 17th. U.S. Physical Therapy’s dividend payout ratio is currently 46.78%.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.